- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07684716
Individualized Non-pharmacological Intervention for Bowel Preparation
July 1, 2026 updated by: Xingshun Qi, General Hospital of Shenyang Military Region
Effect of an Individualized Non-pharmacological Intervention Based on a Predictive Model for Inadequate Bowel Preparation on Bowel Preparation Quality: a Three-arm, Prospective, Randomized Controlled Study
Colonoscopy is essential for the early detection of colorectal cancer.
However, inadequate bowel preparation remains a common challenge, associated with reduced adenoma detection rates, prolonged procedure time, and increased healthcare costs.
Current individualized regimens rely largely on higher laxative dosages-an approach with limited clinical utility.
Non-pharmacological interventions, including dietary modification, physical activity, and health education, are safe and tend to have better patient adherence.
The effectiveness of health education depends largely on message framing.
Guided by information-framing theory, we developed an individualized non-pharmacological regimen.
This randomized controlled trial aims to evaluate the efficacy of this regimen in improving bowel preparation quality.
Study Overview
Status
Recruiting
Conditions
Detailed Description
A total of 339 patients are enrolled and randomly assigned in a 1:1:1 ratio to the information-framing + individualized bowel preparation (BP) group, the individualized BP group, and the control group.
All patients receive oral instructions on bowel preparation.
On this basis, the control group receives a standard BP regimen and written educational materials; the individualized BP group is assessed using a risk prediction model for inadequate bowel preparation, with the results disclosed to the patients.
Those with a risk score ≥3.25 receive an enhanced BP regimen, while those with a risk score <3.25 receive the standard BP regimen, and all patients in this group receive illustrated educational materials.
In the information-framing + individualized BP group, educational materials are further tailored according to the information framework theory.
Specifically, patients with a risk score ≥3.25 receive loss-framed materials emphasizing the harms of non-adherence, whereas those with a score <3.25 receive gain-framed materials highlighting the benefits of adherence.
On the day of the colonoscopy, patients' willingness to undergo a repeat colonoscopy and the occurrence of adverse events are recorded in the waiting area.
Patients also complete the Bowel Preparation Adherence Behavior Assessment Scale and the Treatment Self-Regulation Questionnaire.
Bowel preparation quality is evaluated by endoscopists blinded to group allocation using the Boston Bowel Preparation Scale (BBPS), and polyp/adenoma detection rates are also recorded.
Study Type
Interventional
Enrollment (Estimated)
339
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Xingshun Qi
- Phone Number: +8618909881019
- Email: xingshunqi@126.com
Study Contact Backup
- Name: weiyi wang
- Phone Number: 13019441021
- Email: 373302698@qq.com
Study Locations
-
-
Liaoning
-
Shenyang, Liaoning, China, 110016
- Recruiting
- General Hospital of Northern Theater Command
-
Contact:
- Xingshun Qi
- Phone Number: 13019441024
- Email: xingshunqi@126.com
-
Contact:
- Email: 373302698@qq.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- age ≥ 18 years;
- outpatient scheduled for colonoscopy using oral laxatives for bowel preparation;
- able to understand the study and provide written informed consent.
Exclusion Criteria:
- undergoing emergency colonoscopy;
- suspected intestinal obstruction, stricture, or perforation;
- severe cardiac, cerebral, hepatic, or renal disease;
- severe psychiatric disorder;
- impaired consciousness or communication difficulties;
- pregnancy or lactation;
- previous enrollment in this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard bowel preparation group
Patients receive verbal instructions and printed text-based bowel preparation education materials, along with a standard bowel preparation regimen.
|
Patients receive verbal bowel preparation instruction and printed text-based bowel preparation education materials.
|
|
Experimental: Individualized bowel preparation group
Patients receive verbal instructions and printed illustrated bowel preparation educational materials.
The inadequate bowel preparation risk score is calculated using the established prediction model.
Patients with a risk score ≥ 3.25 receive an enhanced bowel preparation regimen, whereas those with a score < 3.25 receive the standard bowel preparation regimen.
The enhanced bowel preparation regimen is based on the standard protocol, with two additional components.
First, starting 3 days before the colonoscopy, patients are instructed to avoid high-fiber foods and, from 1 day before the colonoscopy, to adopt a semiliquid low-residue diet.
They are also asked to walk for 30 minutes after each meal, with a target of approximately 6,000 steps per day.
Second, after consuming each 500 mL of the polyethylene glycol electrolyte solution and upon finishing the entire solution, patients are asked to chew one piece of sugar-free gum for 10 minutes.
|
Patients receive verbal instructions and printed illustrated bowel preparation educational material.
Patients with a risk score ≥ 3.25 are instructed to take low-residue diet 3 days before colonoscopy and walk for 30 minutes after each meal, with a target of approximately 6,000 steps per day.
After consuming each 500 mL of polyethylene glycol electrolyte solution, and finishing the entire solution, patients are asked to chew one piece of sugar-free gum for 10 minutes.
Patients with a score < 3.25 received the standard bowel preparation regimen.
|
|
Experimental: Information-framing guided individualized bowel preparation group
Patients receive the same interventions as those in the individualized group.
In addition, they receive information-framed educationa material.
For those with an inadequate bowel preparation risk score ≥ 3.25, negatively-framed materials emphasizing the harms of non-adherence are provided; for those with a score < 3.25, positively-framed materials emphasizing the benefits of adherence are provided.
|
Patients receive verbal instructions and printed illustrated bowel preparation educational material.
Patients with a risk score ≥ 3.25 are instructed to take low-residue diet 3 days before colonoscopy and walk for 30 minutes after each meal, with a target of approximately 6,000 steps per day.
After consuming each 500 mL of polyethylene glycol electrolyte solution, and finishing the entire solution, patients are asked to chew one piece of sugar-free gum for 10 minutes.
Patients with a score < 3.25 received the standard bowel preparation regimen.
For those with an inadequate bowel preparation risk score ≥ 3.25, negatively-framed materials emphasizing the harms of non-adherence are provided; for those with a score < 3.25, positively-framed materials emphasizing the benefits of adherence are provided.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bowel preparation quality
Time Frame: Assessed by the endoscopist during colonoscopy procedure
|
Bowel preparation quality is assessed using the Boston Bowel Preparation Scale (BBPS).
Bowel preparation was considered adequate when the total BBPS score was ≥ 6, with each colonic segment score ≥ 2.
|
Assessed by the endoscopist during colonoscopy procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of bowel preparation-related adverse events
Time Frame: Recorded during the waiting period prior to colonoscopy procedure
|
Incidence of nausea, vomiting, abdominal distension, abdominal pain
|
Recorded during the waiting period prior to colonoscopy procedure
|
|
Polyp/adenoma detection rate
Time Frame: Assessed by the endoscopist during colonoscopy procedure
|
Assessed by the endoscopist during colonoscopy procedure
|
|
|
Compliance of bowel preparation
Time Frame: Assessed during the waiting period prior to colonoscopy procedure
|
Compliance of bowel preparation is assessed by Bowel Preparation Adherence Behavior Assessment Scale.
The Bowel Preparation Adherence Behavior Assessment Scale has a total score ranging from 12 to 60, with higher scores indicating better adherence.
|
Assessed during the waiting period prior to colonoscopy procedure
|
|
Willingness to undergo colonoscopy again (yes/no)
Time Frame: Assessed during the waiting period prior to colonoscopy procedure
|
Patients are asked whether they are willing to undergo a repeat colonoscopy.
|
Assessed during the waiting period prior to colonoscopy procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Xingshun Qi, The General Hospital of Northern Theater Command
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 8, 2026
Primary Completion (Estimated)
August 30, 2026
Study Completion (Estimated)
September 30, 2026
Study Registration Dates
First Submitted
June 26, 2026
First Submitted That Met QC Criteria
July 1, 2026
First Posted (Actual)
July 6, 2026
Study Record Updates
Last Update Posted (Actual)
July 6, 2026
Last Update Submitted That Met QC Criteria
July 1, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- XHNKKY-INPI-1.0
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The datasets analyzed during the current study are not publicly available due to ethical considerations.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bowel Preparation for Colonoscopy
-
Universitaire Ziekenhuizen KU LeuvenNorgine BVActive, not recruitingHealthy | Bowel Preparation | Bowel Preparation for Colonoscopy | Bowel Cleansing for ColonoscopyBelgium
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityCangzhou Central Hospital; Guangdong Second Provincial General Hospital; Tianjin... and other collaboratorsNot yet recruitingColonoscopy | Bowel Preparation for Colonoscopy
-
Alexandra Hospital, Athens, GreeceRecruitingBowel Preparation | Preparation for ColonoscopyGreece
-
Hospital Civil de GuadalajaraRecruitingBowel Preparation for ColonoscopyMexico, Panama
-
Changhai HospitalCompletedBowel Preparation for ColonoscopyChina
-
Changhai HospitalThe First Affiliated Hospital of Nanchang University; The Second Hospital of... and other collaboratorsCompletedBowel Preparation for ColonoscopyChina
-
Parc de Salut MarHospital Universitario de CanariasCompletedBowel Preparation for ColonoscopySpain
-
Southern California Institute for Research and...UnknownBowel Preparation for ColonoscopyUnited States
-
Casen Recordati S.L.CompletedBowel Preparation for ColonoscopySpain
-
Brooke Army Medical CenterTakedaCompletedBowel Preparation for ColonoscopyUnited States
Clinical Trials on Standard bowel preparation guidance
-
Hamilton Health Sciences CorporationMcMaster UniversityUnknownAnastomotic Leak | Surgical Site InfectionCanada
-
Makassed General HospitalRecruiting
-
Changhai HospitalXijing Hospital; First People's Hospital of Hangzhou; The First Affiliated Hospital... and other collaboratorsRecruitingColonoscopy | Colonoscopy: Bowel Preparation | IBD (Inflammatory Bowel Disease)China
-
Muhammad AslamRecruiting
-
University of Child Health Sciences and Children...RecruitingBowel Preparation | Colostomy - Stoma | BOWEL ANASTOMOSISPakistan
-
University Medical Center Ho Chi Minh City (UMC)Recruiting
-
Braintree LaboratoriesCompletedBowel Preparation for ColonoscopyUnited States
-
Tongji HospitalCompleted
-
Shaheed Zulfiqar Ali Bhutto Medical UniversityHoly Family Hospital, PakistanCompletedColorectal Surgery | Bowel Preparation | PediatricPakistan
-
Ningbo No. 1 HospitalCompletedBowel Preparation | Post-polypectomy Bleeding | Urgent ColonoscopyChina